Related references
Note: Only part of the references are listed.Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer
Hua Zhang et al.
AMERICAN JOURNAL OF SURGERY (2015)
Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers
Dong Xie et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Prognostic Factors after Stereotactic Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer
Nathan A. Cannon et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Inflammation and cancer: advances and new agents
Shanthini M. Crusz et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients
Guannan Wu et al.
THORACIC CANCER (2015)
The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer
Shunsuke Mori et al.
PLOS ONE (2015)
Lung cancer in Bulgaria - diagnosis, treatment, and factors affecting survival
Zhasmina Mihaylova et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2015)
Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer
D. J. Pinato et al.
BRITISH JOURNAL OF CANCER (2014)
The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer
M. H. Kang et al.
BRITISH JOURNAL OF CANCER (2014)
Cancer Treatment and Survivorship Statistics, 2014
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Prognostic Value of PLR in Various Cancers: A Meta-Analysis
Xin Zhou et al.
PLOS ONE (2014)
Are Neutrophil/Lymphocyte and Platelet/Lymphocyte Rates in Patients with Non-Small Cell Lung Cancer Associated with Treatment Response and Prognosis?
Dilek Unal et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Prognostic Factors in Patients with Advanced Cancer: A Comparison of Clinicopathological Factors and the Development of an Inflammation-Based Prognostic System
Barry J. Laird et al.
CLINICAL CANCER RESEARCH (2013)
Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer
Hongbing Liu et al.
JOURNAL OF THORACIC DISEASE (2013)
Preoperative platelet count in predicting lymph node metastasis and prognosis in patients with non-small cell lung cancer
H. B. Liu et al.
NEOPLASMA (2013)
Previous Lung Diseases and Lung Cancer Risk: A Pooled Analysis From the International Lung Cancer Consortium
Darren R. Brenner et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients
Jon E. Peterson et al.
ANGIOGENESIS (2012)
Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer
S. Cedres et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Association of Nutrition Parameters Including Bioelectrical Impedance and Systemic Inflammatory Response With Quality of Life and Prognosis in Patients With Advanced Non-Small-Cell Lung Cancer: A Prospective Study
Karla Sanchez-Lara et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study
Michael J. Proctor et al.
EUROPEAN JOURNAL OF CANCER (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma
K Hiraoka et al.
BRITISH JOURNAL OF CANCER (2006)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)